|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1996-11-20
|
|
pubmed:abstractText |
The effectiveness of a chemotherapy regimen including cisplatin, epirubicin, and estramustine phosphate was evaluated in a series of young patients with prostate cancer.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
0302-2838
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
434-8
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:8791050-Antibiotics, Antineoplastic,
pubmed-meshheading:8791050-Antineoplastic Agents, Hormonal,
pubmed-meshheading:8791050-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:8791050-Cisplatin,
pubmed-meshheading:8791050-Drug Administration Schedule,
pubmed-meshheading:8791050-Epirubicin,
pubmed-meshheading:8791050-Estramustine,
pubmed-meshheading:8791050-Humans,
pubmed-meshheading:8791050-Male,
pubmed-meshheading:8791050-Middle Aged,
pubmed-meshheading:8791050-Prostatic Neoplasms,
pubmed-meshheading:8791050-Survival Rate,
pubmed-meshheading:8791050-Time Factors,
pubmed-meshheading:8791050-Treatment Outcome
|
|
pubmed:year |
1996
|
|
pubmed:articleTitle |
Multidrug chemotherapy in the treatment of non-elderly patients with hormone-refractory prostatic carcinoma. A phase II study. North-Eastern Italian Oncology Group (GOCCNE).
|
|
pubmed:affiliation |
Division of Preventive Oncology, Centro di Riferimento Oncologico, Aviano, Italy.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Clinical Trial, Phase II
|
